Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.45 |
| ▸ | CTNNB1 | P35222 | 1/20 | 0.45 |
| ▸ | P2RX1 | P51575 | 1/20 | 0.43 |
| ▸ | EGLN2 | Q96KS0 | 1/20 | 0.42 |
| ▸ | CA12 | O43570 | 1/20 | 0.42 |
| ▸ | CA1 | P00915 | 1/20 | 0.42 |
| ▸ | CA2 | P00918 | 1/20 | 0.42 |
| ▸ | CA6 | P23280 | 1/20 | 0.42 |
| ▸ | CA9 | Q16790 | 1/20 | 0.42 |
| ▸ | PARP1 | P09874 | 1/20 | 0.41 |
| ▸ | MTNR1A | P48039 | 2/20 | 0.41 |
| ▸ | MTNR1B | P49286 | 2/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | TP53 | P04637 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | HTT | P42858 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 2/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8790758 | 0.84 | CTNNB1 (0.48) | KDM4ECTNNB1PARP1SMN1; SMN2GAA | |
| SCHEMBL237028 | 0.84 | L3MBTL1 (0.49) | KDM4EALDH1A1PARP1MEN1KMT2A | |
| SCHEMBL13282769 | 0.81 | ALDH1A1 (0.44) | KDM4EALDH1A1P2RX1EGLN2CA12 | |
| SCHEMBL10431600 | 0.76 | CTNNB1 (0.50) | KDM4EALDH1A1CTNNB1P2RX1EGLN2 | |
| SCHEMBL2166736 | 0.76 | NQO2 (0.56) | KDM4EALDH1A1CTNNB1EGLN2CA1 | |
| SCHEMBL11768399 | 0.76 | CA12 (0.52) | KDM4EALDH1A1CTNNB1P2RX1EGLN2 | |
| SCHEMBL7667657 | 0.76 | SPR (0.57) | CA1CA2CA9MTNR1AMTNR1B | |
| SCHEMBL19380935 | 0.74 | TDP1 (0.55) | KDM4EALDH1A1CA12CA2CA6 | |
| SCHEMBL10635884 | 0.74 | CTNNB1 (0.48) | KDM4EALDH1A1CTNNB1P2RX1EGLN2 | |
| SCHEMBL10636256 | 0.73 | CTNNB1 (0.47) | KDM4EALDH1A1CTNNB1CA12CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160130193-A1 | PRODUCTION METHOD FOR OPTICALLY ACTIVE ALCOHOL COMPOUND | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2016-05-12 | — | — | US | disclosed |
| US-20160130193-A1 | PRODUCTION METHOD FOR OPTICALLY ACTIVE ALCOHOL COMPOUND | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2016-05-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160130193-A1 | PRODUCTION METHOD FOR OPTICALLY ACTIVE ALCOHOL COMPOUND | ADH1C, ADH1A, ADH5 | KDM4E 3225/4885ALDH1A1 82/4885CTNNB1 1898/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.